rs3774937 — NFKB1 NFKB1 promoter/regulatory variant

NF-κB1 and Chronic Inflammation — A Locus at the Crossroads of Immune Disease

Nuclear factor kappa B (NF-κB) is the master transcription factor of the human inflammatory response. Every time your immune cells detect a pathogen, sense tissue damage, or respond to cytokine signals, NF-κB activates within minutes — switching on hundreds of target genes for cytokines, chemokines, adhesion molecules, and antimicrobial peptides. The NFKB1 gene encodes p105 and p50, the two critical NF-κB subunits that both drive and regulate this response. rs3774937 is a common intronic variant in NFKB1 that has emerged from large-scale genomic studies as a genuine susceptibility locus for chronic inflammatory disease — reaching genome-wide significance across ulcerative colitis and a pleiotropic analysis of five distinct immune-mediated conditions.

The Mechanism

rs3774937 lies within an intron of NFKB1 at chromosome 4 position 102,513,096 (GRCh38) and does not alter the p105 or p50 protein sequence. Intronic variants can nonetheless influence gene function through several mechanisms: altering splicing enhancer or silencer sequences¹¹ splicing enhancer or silencer sequences
Intronic regulatory elements that guide which exons are included in the final mRNA transcript, modifying transcription factor binding sites embedded within introns, or marking linkage disequilibrium²² linkage disequilibrium
Non-random co-inheritance of alleles at nearby loci; rs3774937 may tag a causal functional variant at the NFKB1 locus without being directly causal itself with a functional variant that has not yet been fully characterized. The nearby rs28362491 variant — a four-nucleotide ATTG insertion-deletion in the NFKB1 5' regulatory region with documented effects on promoter activity — is the most likely functional candidate at this chromosomal location; rs3774937 has been included in NFKB1 haplotype analyses alongside rs28362491, rs230521, rs230510, and rs4648068, suggesting they tag overlapping regulatory variation.

The biological consequence of reduced NF-κB1 p50 activity is a shift in the immune inflammatory set point. The p50 homodimer acts as a transcriptional repressor of pro-inflammatory genes — it competes with the activating p50/p65 heterodimer for DNA binding at NF-κB response elements. Reduced p50 protein means less of this negative feedback, resulting in higher baseline cytokine production and exaggerated inflammatory responses to immune triggers. This mechanism connects reduced NFKB1 transcriptional activity to the observed associations with conditions driven by chronic or dysregulated inflammation.

The Evidence

The strongest evidence comes from genome-wide association studies of inflammatory bowel disease. Liu et al. (2015)³³ Liu et al. (2015)
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nature Genetics. — a trans-ancestry meta-analysis — identified rs3774937 at the NFKB1 locus with genome-wide significance for ulcerative colitis (OR approximately 1.10, p=5×10⁻¹⁴, risk allele frequency 0.33 in the discovery cohort). The modest odds ratio paired with extreme statistical significance across tens of thousands of samples confirms this is a robust genetic association.

Ellinghaus et al. (2016)⁴⁴ Ellinghaus et al. (2016)
Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nature Genetics. conducted a pleiotropy analysis in over 86,000 European-ancestry individuals across ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, and ulcerative colitis. The NFKB1 locus (tagged by rs3774937) reached p=2×10⁻¹⁸ in the cross-disease analysis — among the most significant signals in the entire study. This pleiotropic signal indicates that the same regulatory variation at NFKB1 contributes to multiple distinct immune-mediated conditions, consistent with NF-κB1's role as a central node in immune homeostasis rather than a disease-specific factor.

Beyond IBD and autoimmune phenotypes, Cabrera et al. (2014)⁵⁵ Cabrera et al. (2014)
Intronic variants in the NFKB1 gene may influence hearing forecast in patients with unilateral sensorineural hearing loss in Menière's disease. PLoS One. reported that rs3774937 C allele carriers with unilateral Menière's disease reach hearing stage 3 (greater than 40 dB loss) significantly faster than non-carriers (p=0.009, log-rank corrected). The study enrolled 716 Menière's disease cases and 1,628 controls — the association was specific to unilateral disease, consistent with an inflammatory component in the inner ear lesion driven by NF-κB1 pathway variation.

In the transplant setting, Kuba et al. (2020)⁶⁶ Kuba et al. (2020)
NFKB1 gene single-nucleotide polymorphisms: implications for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Annals of Hematology. reported strong association of rs3774937 genotype with acute graft-versus-host disease in 109 transplant recipients — evidence that the variant influences post-transplant immune responses, where NF-κB signaling governs allogeneic T cell activation and cytokine production.

Practical Actions

The per-allele OR of approximately 1.10 for ulcerative colitis and similarly modest effect sizes for other conditions mean that rs3774937 does not determine disease fate — it tilts the immune landscape modestly in the direction of dysregulated inflammatory signaling. For CC homozygotes (~9% of Europeans), two copies compound this tilt. The actionable consequence is proactive monitoring of inflammatory burden and support for the NF-κB regulatory mechanisms this locus influences.

Monitoring circulating biomarkers of systemic inflammation — particularly high-sensitivity CRP (hsCRP) and calprotectin if gastrointestinal symptoms arise — provides direct insight into whether this genetic signal is translating into detectable inflammatory activity in the individual. Omega-3 fatty acids at therapeutic doses reduce NF-κB activation and downstream cytokine production through resolvin and protectin pathways that directly intersect with the NF-κB signaling axis.

Interactions

rs3774937 sits within the same NFKB1 genomic region as several other variants studied in this encyclopedia: rs28362491 (the -94ATTG functional indel in the NFKB1 5' regulatory region, associated with cardiovascular and autoimmune risk), rs230523 (intronic NFKB1 variant associated with infection susceptibility), and rs4648127 (a rare protective intronic variant associated with reduced lung cancer risk). These variants are in partial linkage disequilibrium and may partly tag the same causal signal — users who carry risk alleles at multiple NFKB1 intronic positions should treat their combined signal with caution to avoid double-counting the same underlying regulatory effect.

TLR4 (rs4986790) and TLR1 (rs5743708) variants acting upstream of NF-κB activation may compound with NFKB1 variants to produce additive reductions in pathogen-driven immune gene expression when both receptor-level and transcription-factor-level variation co-occur.